Gynecological Cancer

Panel 12 - (INTERACTIVE) Volumetric Brachytherapy for Gynecologic Cancers: What is New, What is Essential and What is Feasible?

10/23/2018
2:45 PM - 4:15 PM
Location: Room 214 A/B

Session Type: Panel
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits

This session will focus on the pivotal role of image-guided adaptive brachytherapy in curing cervical cancer. The most current practice-altering data will be summarized from the EMBRACE I and II trials as well as the Retro-EMBRACE study. The attendees will also focus on key elements of the ICRU 89 report which has set a new standard for image guided brachytherapy. In addition, a practical approach to imaging options, applicator selection, including hybrid options and applicator insertion settings (OR vs. departmental suite or simulator) will be explored. What is new, what is essential and what is feasible will be emphasized.

Learning Objectives:

Presentations:

Beth Erickson, MD, FASTRO

Disclosure:
Employment
Medical College of Wisconsin: MD Professor of Radiation Oncology: Employee; ProHealth Care, Waukesha, WI: MD: Employee

Leadership
American Brachytherapy Society: Steering committee; Elekta: Pancreas TSG chair

Biography:
Dr. Beth Erickson is tenured professor and faculty at the Medical College of Wisconsin, Department of Radiation Oncology. Dr. Erickson focuses on treatment of patients with gastrointestinal and gynecologic cancers and is chief of Brachytherapy Services at MCW. She has written and spoken nationally and internationally on treatment of gynecologic and GI malignancies, with special interest in image-based treatment planning both for external-beam and brachytherapy. She has great interest in MR-guided radiation and currently has an investigator-initiated trial, MR-guided phase-II radiotherapy dose-escalation in unresectable non-metastatic pancreatic cancer. Dr. Erickson currently chairs the tumor-site group for pancreas cancer for the International MRI-Linac Consortium. She served on the ICRU-89 committee and has participated in the MR-based EMBRACE trial. She has been active in the American Brachytherapy Society, serving as a member of the board and past president, along with the ABS GYN Brachytherapy School since its inception in 1995. She was honored with the Henschke Award in 2014. She currently serves as chair of the ABS International committee. She serves as section-head editor for Gyn for the “Journal of Brachytherapy International”. Dr. Erickson served as Vice-Chair of the Cervix Committee for the Patterns of Care and QRRO Studies and has served as Chair of the ACR Practice Guidelines for the performance of high-dose rate and low-dose rate brachytherapy. She served on the Cervix Committee for NRG. She has also been active in the Radiological Society of North America serving as co-chair for the Boost Program. She is a former trustee of the American Board of Radiology. She served on the RRC. She has been very active in ASTRO with teaching activities including multiple ASTRO refresher courses, panels, and e-contouring courses along with serving on numerous ASTRO committees including the MOC/CME, Education, Nominating, Fellowship and Refresher course and serving as Gyn Track Chair.

Presentation(s):

Send Email for Beth Erickson


Assets

Panel 12 - (INTERACTIVE) Volumetric Brachytherapy for Gynecologic Cancers: What is New, What is Essential and What is Feasible?



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Panel 12 - (INTERACTIVE) Volumetric Brachytherapy for Gynecologic Cancers: What is New, What is Essential and What is Feasible?